The U.S. Defense Health Agency has selected Parsons Corporation for the Omnibus IV Military Medical Research and Development contract to provide health-related research and development for the Department of Defense and the Military Healthcare System, according to a news release Thursday.
The contract is a five-year multiple-award indefinite delivery/indefinite quantity contract with one five-year option period and has a $10 billion ceiling value, according to Parsons.
Parsons will compete for task orders in Market Segment 2, R&D Support Services, the technology provider said.
This story was produced by Bloomberg Law Automation.
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.